GC
PLRX icon

Grace Capital’s Pliant Therapeutics PLRX Stock Holding History

Grace Capital’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$776K Buy
57,471
+9,413
+20% +$150K 0.46% 66
2021
Q3 		$808K Sell
48,058
-9,750
-17% -$207K 0.5% 63
2021
Q2 		$1.68M Buy
57,808
+19,650
+51% +$612K 1.13% 22
2021
Q1 		$1.48M Buy
38,158
+30,308
+386% +$984K 0.94% 24
2020
Q4 		$178K Buy
7,850
+750
+11% +$18.8K 0.11% 158
2020
Q3 		$160K Buy
7,100
+1,100
+18% +$27.5K 0.12% 143
2020
Q2 		$195K Buy
+6,000
New +$159K 0.17% 123

Other funds holding PLRX

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Grace Capital's PLRX Position: Q4 2021 in Review

Grace Capital increased its Pliant Therapeutics (PLRX) stake by 20% in Q4 2021, buying an estimated $150K and bringing the position to 57,471 shares worth $776K. The position accounts for 0.46% of the portfolio, ranked #66.

Grace Capital first reported a position in PLRX in Q2 2020 and has held it in 7 quarters since. The position peaked at $1.68M in Q2 2021. 88 funds tracked by Wall St. Rank hold PLRX as of Q4 2021.

  • Grace Capital held 57,471 shares of Pliant Therapeutics worth $776K as of Q4 2021.
  • Grace Capital bought 9,413 Pliant Therapeutics shares in Q4 2021, an estimated $150K.
  • Pliant Therapeutics made up 0.46% of Grace Capital's portfolio in Q4 2021, its #66 holding.
  • Grace Capital first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 7 quarters since.
  • Grace Capital's Pliant Therapeutics position peaked at $1.68M in Q2 2021.
  • 88 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2021.

Based on Grace Capital's 13F filing for Q4 2021, filed 2 Feb 2022.